Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Merck"


25 mentions found


Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAI is driving semiconductor industry, says CEO Electronics at Merck KgaAKai Beckmann, a member of the executive board and the CEO Electronics at Merck KgaA, discusses the use of AI in the semiconductor industry.
Persons: Merck KgaA Kai Beckmann Organizations: Merck, Merck KgaA
Merck plans to discuss the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season, according to a release. The trial examined the safety and efficacy of a single dose of the treatment, clesrovimab, in healthy preterm and full-term infants entering their first RSV season. Results were consistent through both the five-month and six-month time points in the trial, Merck said. Merck's clesrovimab could potentially compete against a similar treatment from Sanofi and AstraZeneca called Beyfortus, which was in short supply nationwide last RSV season due to unprecedented demand. But Merck's treatment can be administered to infants regardless of their weight, which the company said may offer convenience in terms of dosing.
Persons: Merck, Clesrovimab, Dr, Octavio Ramilo, Ramilo, Merck's Organizations: Merck, New York Stock Exchange, Infectious, Research, Sanofi, AstraZeneca, Pfizer, GSK Locations: Los Angeles, St
But opponents ignore both the history of so-called meritocracy, and the fact that DEI programs benefit business, Frazier and Chenault argue. But they said opponents have weaponized select examples of diversity programs that are not practiced widely to oppose DEI entirely. Brandon Bell/Getty ImagesMeanwhile, conservative legal groups are now filing lawsuits targeting companies’ diversity initiatives, and Republican leaders like Florida Gov. Frazier and Chenault said there was a split between companies that rushed to create diversity programs in the wake of George Floyd’s murder in 2020 and companies that have embedded these programs into their business. “For those companies that had integrated DEI into the way they do business, fundamentally, it’s marbled into the meat, so to speak.
Persons: Ken Frazier, Ken Chenault, Ken Chenault’s, John Deere, Davidson, Bud Light’s, Frazier, ” Frazier, America’s “, Elon, Chenault, Roy Vagelos —, — Frazier, Vagelos, weren’t, Merck, , ” Chenault, don’t, George Floyd, Brandon Bell, Ron DeSantis, Arkansas Sen, Tom Cotton, Bud Light, Robby Starbuck, Starbuck, George Floyd’s, They’re, Organizations: New, New York CNN, America, Merck, Black, American Express, Fortune, CNN, Corporate America, Tractor Supply, Boston Consulting Group, DEI, Revelio Labs, White, ” Companies, McKinsey, Republican, Florida Gov, Disney, Nike, Harley Locations: New York, Philadelphia, America, Arkansas
Cramer's Lightning Round: 'I like Target right here'
  + stars: | 2024-10-08 | by ( Julie Coleman | ) www.cnbc.com   time to read: +1 min
Stock Chart Icon Stock chart icon Unity Software's year-to-date stock performance. Stock Chart Icon Stock chart icon Alumis' year-to-date stock performance. Stock Chart Icon Stock chart icon Target's year-to-date stock performance. Stock Chart Icon Stock chart icon SoundHound AI's year-to-date stock performance. Stock Chart Icon Stock chart icon Merck's year-to-date stock performance.
Persons: Alumis, It's, SoundHound Organizations: Unity Software, Merck
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Buy Target here, then wait another 5 points and buy more, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Unity, Alumis, Target, SoundHound, Merck, and more.
Persons: Jim Cramer Organizations: Merck
Democratic presidential nominee and U.S. Vice President Kamala Harris speaks onstage during a campaign event, in Las Vegas, Nevada, U.S., September 29, 2024. Business Leaders for Harris went live with a website early Friday that features online testimonials, both from small business owners and hugely successful entrepreneurs. We need someone who will bring us hope in a very tangible way and that is Kamala Harris," Chenault says in his testimonial. Business Leaders for Harris is a project of the Republican Accountability PAC, a progressive political action committee. In addition to donating money, Hoffman is hosting a new Business Leaders for Harris podcast.
Persons: Kamala Harris, Donald Trump, Harris, Mark Cuban, Reid Hoffman, Reed Hastings, Aaron Levine, Ken Chenault, Ken Frazier, Chenault, Hastings, Joe Biden, Biden, Hoffman, they're Organizations: Democratic, U.S, Republican, Donald Trump . Business, Dallas Mavericks, LinkedIn, Netflix, Former American Express, Merck, Trump ., Business, PAC, Commission, Harris, Cuban Locations: Las Vegas , Nevada, U.S, Hastings
A group of founders and CEOs are launching "Business Leaders for Harris." It includes several business titans, including Mark Cuban, who've already been backing Harris. AdvertisementA group of CEO and founders are launching a new initiative on Friday called "Business Leader for Harris" — aiming to woo business-minded, conservative-leaning swing voters to support Vice President Kamala Harris. The initiative is led by a group of business titans that includes LinkedIn cofounder Reid Hoffman, billionaire investor Mark Cuban, and Netflix cofounder Reed Hastings. Advertisement"When it comes to true business, doing business, she is completely open-minded, right?
Persons: Harris, Mark Cuban, who've, , Kamala Harris, Reid Hoffman, Reed Hastings, Donald Trump, Trump, Ken Frazier, Trump's, Hastings, Hoffman, Biden, She's Organizations: Service, titans, Netflix, Merck, Penn Wharton Budget, Biden, Cuban Locations: Charlottesville
A major stimulus deal coming out of China could offer a windfall for some U.S. stocks with significant ties to the world's second-largest economy, according to Barclays. Against this backdrop, the firm screened for companies with high sales exposure to China and low volatility. Here are some of the potential winners: Barclays named casino and resort operator Wynn Resorts among the beneficiaries of a China stimulus deal, with 48% sales exposure to China. Qualcomm is another winner, with 62% sales exposure to China and the second-highest among the stocks that made the cut. Some underperforming stocks could also benefit from China's stimulus plan, including Albemarle .
Persons: Stefano Pascale, Pascale Organizations: Barclays, Wynn Resorts, Qualcomm, Merck, Western Locations: China, Albemarle
CNBC is now accepting nominations for our second annual Changemakers list. The list recognizes women transforming business and philanthropy, female leaders who have accomplished a meaningful achievement in 2024. Changemakers are taking novel approaches to old business problems and identifying new business opportunities. The list will be announced next year, and our second annual Changemakers Summit is set for next spring. Submit a nomination for the 2025 Changemakers list.
Persons: Dina Powell McCormick, Donald Trump, Marcela Miguel Berland, Tory Burch, Burch, Emma Carrasco, Corporate Affairs Srikant Datar, Harvard Business School Dean Karen Finerman, Ken Frazier, Desiree Gruber, Oscar Munoz, Laurene Powell Jobs, Emerson, Merline Saintil, Sheryl Sandberg, Stacy Smith, Spencer Stuart Organizations: CNBC, Fortune, Global Client Services, U.S . Deputy National, Tory, NBCUniversal, Corporate Affairs, Harvard Business School, Metropolitan Capital, Catalyst's Health, Merck, United Airlines, OptionB.org, Annenberg, LeanIn, McKinsey
Trump, more so than any American president in modern history, has directly targeted individual US businesses, threatening them with everything from boycotts and canceled federal contracts to unthinkably high tariffs. Deere, the farm equipment maker founded nearly 200 years ago, became just the latest storied brand to get singled out by Trump. Bigger picture, the attack on Deere fits a broader pattern of Trump bullying companies when it suits him. “John Deere is an outstanding company. “Ultimately, it would lead to fewer sales, less revenue, less growth and fewer employees for John Deere,” said McDaniel, now a senior research fellow at George Mason University’s Mercatus Center.
Persons: New York CNN —, John Deere, they’ve, Donald Trump, Trump, “ Trump, Bill George, , Nordstrom, Ken Frazier, Donald J, Trump’s, Julian Zelizer, Harry Truman, John F, Kennedy, Teddy Roosevelt, , Zelizer, ” Zelizer, ’ Trump, “ I’m, we’ll, ” Trump, George, “ John Deere, ” Christine McDaniel, George W, Bush, Deere, McDaniel, George Mason University’s, Billionaire Mark Cuban, Kamala Harris, Washington, Mary Lovely, ” Lovely Organizations: New, New York CNN, New York CNN — Apple, General Motors, Facebook, Trump, Deere, CNN, White, Apple, San Bernardino, FBI, US Postal Service, Boeing, Air Force, Motors, Merck, Meta, CNBC, Google, Princeton University, Harvard University, Center, Billionaire, Fox News, Street Journal, Peterson Institute for International Economics Locations: New York, Midwest, Mexico, San, Charlottesville , Virginia, United States, Pennsylvania, American, North America, Canada
The table and chart below illustrate some characteristics of the biopharma stocks. The average price/earnings multiple for the group, using 2025 estimates, is 12.7 times versus 20.6 times for the S & P 500. A major knock on the biopharma group is the limited productivity from their extremely expensive research efforts, other than obesity drugs, over the past twenty-five years. The technology using AI might not be ready yet, particularly related to the complex biology of the human body. Complex programs exist already, such as AlphaFold, which predicts the structure of three-dimensional compounds using data on protein sequences.
Persons: Bristol Myers, Amgen, Eli Lilly, Lilly, Johnson Organizations: CNBC, Merck, Pfizer, Novo Nordisk, JPMorgan Locations: Bristol
The company's stock price has surged by over 1,100% in the past 12 months, lifting its market value to over $16 billion. Summit stock jumped from about $12 on September 6 to a record high of $32 on September 13, but has retreated to around $23 since then. Spurred on by his son's death from brain cancer, Duggan started building a stake in Pharmacyclics, a maker of cancer drugs, in 2004. Pharmaceutical titan AbbVie bought the business for $21 billion in cash and stock in 2015, netting Duggan more than $3 billion, per Bloomberg. He joined Summit's board in 2019 and became CEO and chairman in 2020, making cancer drugs his principal focus.
Persons: , Bob Duggan, Duggan, AbbVie Organizations: Service, Summit Therapeutics, Bloomberg, Business, Summit, UC Santa Barbara, Wall Street Journal, Computer, of Scientology, Duggan Investments Locations: Pharmacyclics
This report is from this week's CNBC's "Inside India" newsletter which brings you timely, insightful news and market commentary on the emerging powerhouse and the big businesses behind its meteoric rise. Its intent was clear: to develop India's manufacturing capabilities in sectors like automotives, electronics, pharmaceuticals and aerospace while creating opportunities for locals. India's manufacturing sector has seen "remarkable" growth says, Samir Kapadia, founder and CEO of B2B marketplace India Index. "These infrastructural shifts in India have improved connectivity within and outside the country putting India at a very different playing field than it was 10 years ago when 'Make in India' started," Kapadia told CNBC's Inside India. India vs. other emerging marketsWhile India looks to poach China's manufacturing share, other countries like Indonesia, Vietnam, Bangladesh and Mexico are also stiff competitors.
Persons: Wistron, Narendra Modi, Foxconn, Samir Kapadia, Kapadia, CNBC's, U.S . Franklin Templeton's Yi Ping Liao, Liao, Deveshwar Organizations: Tata Group, Indian, Apple, Dixon Technologies, Kia, Divi's, Novartis, GSK, Merck, China, U.S ., TS Lombard, Inside, Mutual Fund Locations: India, China, Silicon Valley, Bengaluru, Kolar, Doddaballapura, Foxconn, Kia India, Anantapur —, Indonesia, Vietnam, Bangladesh, Mexico, Asia, Inside India, Brazil
Interest in India has been rising steadily among investors, thanks to its growing economy , strong stock market performance and burgeoning population . Amid some talk of an Indian stock market bubble , however, Pramod Gubbi, co-founder of Marcellus Investment Managers, revealed how he is playing the market. So, our job is to evaluate whether the management teams are hungry enough to identify changes that are happening and adapt to them," he told CNBC Pro last week. Women-led themes One theme that Gubbi is interested in is how India's growing numbers of working women are spending their money. Other stocks Other Indian companies Gubbi likes include Divi's Laboratories and HDFC Bank .
Persons: Pramod Gubbi, Marcellus, Gubbi, Maggi, Nescafe Organizations: Marcellus Investment, Management, CNBC Pro, Bombay Stock Exchange, Tata Group, Brands, Nestle, , Paints, Divi's Laboratories, HDFC Bank, Novartis, GSK, Merck Locations: India, U.S, China
Check out the companies making headlines in midday trading: Palantir Technologies , Dell Technologies — Palantir and Dell jumped 14% and nearly 4%, respectively, following the announcement after the bell Friday that both stocks would join the S & P 500 before the open on Sept. 23. Palantir is set to take American Airlines' spot, while Dell is going to replace Etsy. JetBlue Airways — The airline stock popped around 7% after Bank of America analyst Andrew Didora upgraded the firm to neutral from underperform. Cannabis stocks — Cannabis stocks moved higher after former President Donald Trump said in a Truth Social post that he will support legalizing adult marijuana use in Florida. A logo outside the Palantir Technologies pavilion ahead of the World Economic Forum in Davos, Switzerland, on Jan. 15, 2024.
Persons: Dell, Merck's, Andrew Didora, Didora, Arm's, Donald Trump, , Alex Harring, Hakyung Kim, Yun Li, Jesse Pound, Michelle Fox, Stefan Wermuth Organizations: Palantir Technologies, Dell Technologies, American Airlines, Etsy, Therapeutics, Merck, JetBlue Airways —, Bank of America, JetBlue, Boeing, Citi, Federal Reserve, Arm Holdings, Financial, Apple, Monday, United States Steel, JPMorgan, Nippon Steel, Tilray Brands, Cannabis ETF, Economic, Bloomberg, Getty Locations: Florida, Davos, Switzerland
MarineMax — Shares jumped 6% after Citi upgraded shares to buy from neutral. Palantir Technologies , Dell Technologies — Shares of Palantir and Dell rallied 8% and 5%, respectively, after it was announced postmarket Friday that the stocks would join the S & P 500 index. Palantir will replace American Airlines , while Dell will replace Etsy . Summit shares soared more than 30%. United States Steel — Shares moved about 3% higher after JPMorgan upgraded the industrial stock to overweight from neutral.
Persons: Merck, Summit, , Jesse Pound, Hakyung Kim, Sarah Min, Sean Conlon Organizations: Boeing —, Citi, Technologies, Dell Technologies, Dell, American Airlines, Etsy, Summit Therapeutics, Summit, Arm Holdings, Times, Apple, United States Steel, JPMorgan, Nippon Steel, JetBlue Airways —, Bank of America, JetBlue
In 2023, mass-tort lawyers spent $152 million on TV ads and millions more on social media. The data provider X Ante estimated that in 2023, mass-tort lawyers spent $152 million on TV ads and millions more on social media. The decades that followed mass torts' onset on the national stage showed the big risks and big rewards of mass torts. AdvertisementIn a class action, a settlement is public, and the judge has to approve the lawyers' fees. But others are confident that indebted mass-tort lawyers can bounce back from a few bad bets.
Persons: Mike Papantonio, Pap, Johnson, Paul Cody, Bayer, Chris Seeger, audibles, Budd, Ness Motley, Motley Rice, South Carolina —, doling, Seeger, Wyeth, Phil Federico, Paul Hanly who'd, Federico, Lejeune, who've, Camp Lejeune, mack, Curt Miner, I've, Don Worley, Worley, , Daniel A, Mark Lanier, wouldn't, Elizabeth Chamblee Burch, Burch, Ellen Relkin, Merck, Vioxx, There's, Lucian Pera, Keller Postman, Jeremy Troxel, Keller, Troxel, Michael McDonald, Warren Postman, Postman, Kelsey Vlamis, Jack Newsham Organizations: Wynn, Vegas, Camp Lejeune, pharma, Supreme, X, Pfizer, Defense, Marines, Veterans, Foreign, US Marine Corps, Johnson, University of Georgia, Business, Intuit, Rihanna, Morning Investments, Fortress Investment, Gramercy Funds, Deepwater, Investments Locations: Camp, Texas, South Carolina, Baltimore, North Carolina, Camp Lejeune, America, Beverly Hills , California, nonbanks
United States Steel — The industrial stock plunged 6% after Vice President Kamala Harris opposed the planned sale of United States Steel to Japan's Nippon Steel. She made these statements during a Labor Day rally in front of union members in Pittsburgh, Pennsylvania, where she said that United States Steel was "an historic American company and it is vital for our country to maintain strong American steel companies." NetApp — The data storage stock added 1.6% following an upgrade to buy from hold at Loop Capital. Loop analyst Ananda Baruah listed several catalysts, including NetApp's cloud storage software partnerships and a recent pullback. Bank of America — The bank stock was down fractionally.
Persons: Kamala Harris, Wells, Matthew Akers, Morgan Stanley, Ananda Baruah, Jefferies, Peter Welford, Warren Buffett's Berkshire, Merck's Keytruda, — CNBC's Michelle Fox, Jesse Pound Organizations: United States Steel, Japan's Nippon Steel, Labor, Boeing, Software, Novartis —, Novartis, Bank of America, Warren Buffett's Berkshire Hathaway, Merck, European Commission Locations: Pittsburgh , Pennsylvania, American, Warren
The drug company Lykos Therapeutics had spent much of this year expecting to vault to meteoric heights. It had sent an application to the Food and Drug Administration seeking approval to use MDMA to treat post-traumatic stress disorder. It was the capstone to months of increasingly loud concerns being voiced over the quality of Lykos’s clinical trials. Lykos has spent years conducting clinical trials testing whether MDMA-assisted psychotherapy could alleviate the symptoms of PTSD. Its most recent drug trial showed that more than 86 percent of people treated had a measurable reduction in symptom severity.
Persons: , Lykos Organizations: Lykos Therapeutics, Food and Drug Administration, Lykos, Merck
At least, that's what data security experts like Matt Radolec, vice president of incident response at data security company Varonis, say. "Copilots have pass-through permissions," Radolec said. There's also value in proceeding at a slow and steady pace with gen AI processes. Instead, Ensono is developing its own tool so the company can better enable and control its data security. Gen AI has made cybersecurity mistakes costlier, and insiders now pose a bigger threat — malicious or otherwise — than ever before.
Persons: Matt Radolec, GitHub, Salesforce's Einstein, Radolec, it's, they've, Shawnee Delaney, Uber, Delaney, Meredith Graham, I'm, Graham, costlier Organizations: Istock, Getty, Vaillance Group, Defense Intelligence Agency, Merck, Microsoft Locations:
The buzz around artificial intelligence may have quietened after a volatile week for some of the sector's biggest names, but Morgan Stanley continues to see promise in a raft of European stocks. Morgan Stanley's "European AI shopping list" includes names ranging from semiconductor equipment and data center plays to software and healthcare companies. Morgan Stanley has a target price of 1,000 euros ($1,092) on the stock, giving it over 27.5% potential upside. Segro Morgan Stanley describes British REIT Segro as the "landlord of Europe's largest cluster of data centers." Morgan Stanley has a target price of 224 euros on the stock, giving it around 18.3% upside potential.
Persons: Morgan Stanley, Morgan Stanley's, ASML Morgan Stanley, Lee Simpson, ASML's, Simpson, Segro Morgan Stanley, Segro, Bart Gysens, SAP Morgan Stanley, Adam Wood, Merck KGaA, Morgan, Thibault Boutherin, Boutherin, — CNBC's Michael Bloom Organizations: Apple, Euronext, Nasdaq, London Stock Exchange, Euronext Paris, American Depository, SAP, Frankfurt Stock Exchange, New York Stock Exchange, Merck, EMD Group, Canada, Merck KGaA's Electronics Locations: Europe, TSMC, Euronext Amsterdam, U.S, United States, Frankfurt
However, investors can continue generating portfolio income if they snap up the right dividend stocks. Dividend yields that are too high may also raise the question of whether the company can sustain these payments to investors. Data storage player Seagate Technology made the cut, with a three-year annualized dividend yield of 7.9%, according to Bank of America's analysis. Bank of America rates KeyCorp as a buy, and it sees the company and its peers benefiting as the Fed dials back its policy. Devon, which the bank rates as a buy, this week surpassed the Street's estimates on core earnings per share in the second quarter, per FactSet.
Persons: Savita Subramanian, Wamsi Mohan, Mohan, Ebrahim Poonawala, Kraft, Merck Organizations: Federal Reserve, FedWatch, Bank of America, Seagate Technology, Bank of, KeyCorp, Devon Energy, Kraft Heinz, Simon Property Group Locations: Devon, Bank
Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and diabetes drugs, quieting any lingering investor concerns in the stock. Eli Lilly Why we own it: Eli Lilly's best-in-class drugs should enable growth above the industry average for many years to come. The report left little doubt that Eli Lilly's best days are ahead, driven by the growth of GLP-1s. It's really early" for Zepbound, Eli Lilly CEO David Ricks said in a CNBC interview Thursday. But the good news is Eli Lilly's multibillion dollar investments to expand manufacturing capacity are paying off.
Persons: Eli Lilly, Eli Lilly's, Zepbound, Jim Cramer, Lilly, David Ricks, It's, We're, Eli Lilly hasn't, Novo, spooked Lilly, Gordon Brooks, it's, Ricks, Brooks, Verzenio, , didn't, Jim Cramer's, Jim, George Frey Organizations: Revenue, LSEG, Novo Nordisk, Biogen, Merck, Pfizer, CNBC, Food and Drug Administration, Viking Therapeutics, Novo Nordisk —, FDA, RTP, Bloomberg, Getty Locations: Eisai, U.S, GLP, Roche, it's, Indianapolis, North Carolina, Europe, Germany, Provo , Utah
The first round of Medicare drug price negotiations has come to an end – but we still don't know the final prices that the U.S. government and pharmaceutical companies have agreed on. They all maintain that Medicare drug price negotiations are a long-term threat to the pharmaceutical industry's drug innovation and profits, but the immediate dust has somewhat settled. That's based on executive commentary during the recent quarterly earnings calls of Bristol Myers Squibb and Johnson & Johnson , among other companies. Novartis CEO Vasant Narasimhan said on July 18 that the short-term impact from Medicare drug price negotiations "might be manageable on our first set of drugs." Executives at each of the drugmakers similarly emphasized their opposition to Medicare drug price negotiations on their respective earnings calls.
Persons: Joe Biden, Johnson, Joe Biden's, Christopher Boerner, Bristol Myers, Robert Michael, We've, Michael, Jennifer Taubert, Vasant Narasimhan, Narasimhan, Bristol Myers Squibb's Boerner, Boehringer Ingelheim, Annika Organizations: National Institutes of Health, Medicare, Bristol Myers Squibb, Johnson, Pfizer, J, Novartis, Merck, Novo Nordisk, AstraZeneca Locations: Bethesda , Maryland, U.S, annikakim.constantino@nbcuni.com
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trade: Amazon, Berkshire Hathaway, Merck and U.S. 10 Year TreasuryThe final trades of the day with the Fast Money traders.
Persons: Berkshire Hathaway Organizations: Merck, Fast Money Locations: Amazon, Berkshire
Total: 25